Literature DB >> 26011197

Perioperative Allogeneic Blood Transfusion Is Associated With Surgical Site Infection After Abdominoperineal Resection-a Space for the Implementation of Patient Blood Management Strategies.

Kensuke Kaneko1, Kazushige Kawai, Nelson H Tsuno, Soichiro Ishihara, Hironori Yamaguchi, Eiji Sunami, Toshiaki Watanabe.   

Abstract

Allogeneic blood transfusion (ABT) has been reported as a major risk factor for surgical site infection (SSI) in patients undergoing colorectal surgery. However, the association of ABT with SSI in patients undergoing abdominoperineal resection (APR) and total pelvic exenteration (TPE) still remains to be evaluated. Here, we aim to elucidate this association. The medical records of all patients undergoing APR and TPE at our institution in the period between January 2000 and December 2012 were reviewed. Patients without SSI (no SSI group) were compared with patients who developed SSI (SSI group), in terms of clinicopathologic features, including ABT. In addition, data for 262 patients who underwent transabdominal rectal resection at our institution in the same period were also enrolled, and their data on differential leukocyte counts were evaluated. Multivariate analysis showed that intraoperative transfusion was an independent predictive factor for SSI after APR and TPE (P = 0.004). In addition, the first-operative day lymphocyte count of patients undergoing APR, TPE, and transabdominal rectal resection was significantly higher in nontransfusion patients compared with transfusion ones (P = 0.026). ABT in the perioperative period of APR and TPE may have an important immunomodulatory effect, leading to an increased incidence of SSI. This fact should be carefully considered, and efforts to avoid allogeneic blood exposure while still achieving adequate patient blood management would be very important for patients undergoing APR and TPE as well.

Entities:  

Keywords:  Abdominoperineal resection; Allogeneic blood transfusion; Colorectal cancer; Patient blood management; Surgical site infection

Mesh:

Year:  2015        PMID: 26011197      PMCID: PMC4452965          DOI: 10.9738/INTSURG-D-14-00174.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  31 in total

1.  Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients.

Authors:  R Tang; H H Chen; Y L Wang; C R Changchien; J S Chen; K C Hsu; J M Chiang; J Y Wang
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Am J Infect Control       Date:  1992-10       Impact factor: 2.918

Review 4.  Immunomodulation and blood transfusion.

Authors:  Morris A Blajchman
Journal:  Am J Ther       Date:  2002 Sep-Oct       Impact factor: 2.688

5.  Perioperative blood transfusion is predictive of poststernotomy surgical site infection: marker for morbidity or true immunosuppressant?

Authors:  Thomas R Talbot; Erika M C D'Agata; Vicki Brinsko; Byron Lee; Theodore Speroff; William Schaffner
Journal:  Clin Infect Dis       Date:  2004-04-28       Impact factor: 9.079

6.  Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure.

Authors:  Kelli M Bullard; Judith L Trudel; Nancy N Baxter; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

7.  Risk factors for surgical site infection after elective resection for rectal cancer. A multivariate analysis on 2131 patients.

Authors:  S Biondo; E Kreisler; D Fraccalvieri; E E Basany; A Codina-Cazador; H Ortiz
Journal:  Colorectal Dis       Date:  2012-03       Impact factor: 3.788

8.  Surgical site infection in elective operations for colorectal cancer after the application of preventive measures.

Authors:  Xavier Serra-Aracil; María Isabel García-Domingo; David Parés; Eloi Espin-Basany; Sebastiano Biondo; Xavier Guirao; Carola Orrego; Antonio Sitges-Serra
Journal:  Arch Surg       Date:  2011-05

Review 9.  From bloodless surgery to patient blood management.

Authors:  Aryeh Shander; Mazyar Javidroozi; Seth Perelman; Thomas Puzio; Gregg Lobel
Journal:  Mt Sinai J Med       Date:  2012 Jan-Feb

10.  Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.

Authors:  M M Heiss; P Fraunberger; C Delanoff; R Stets; H Allgayer; M A Ströhlein; A Tarabichi; E Faist; K W Jauch; F W Schildberg
Journal:  Shock       Date:  1997-12       Impact factor: 3.454

View more
  3 in total

1.  Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy.

Authors:  Sumer K Wallace; Jessica W Halverson; Christopher J Jankowski; Stephanie R DeJong; Amy L Weaver; Megan R Weinhold; Bijan J Borah; James P Moriarty; William A Cliby; Daryl J Kor; Andrew A Higgins; Hilary A Otto; Sean C Dowdy; Jamie N Bakkum-Gamez
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

2.  Surgical Healthcare Workers Knowledge and Attitude on Infection Prevention and Control: A Case of Tamale Teaching Hospital, Ghana.

Authors:  Abdul Rauf Alhassan; E D Kuugbee; E M Der
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-04-23       Impact factor: 2.471

3.  Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries.

Authors:  Kevin A Nguyen; Danny Q Le; Yvonne T Bui; Sonali D Advani; Joseph Renzulli; Patrick A Kenney; Michael S Leapman
Journal:  World J Urol       Date:  2021-01-20       Impact factor: 4.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.